Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00073125 · ClinicalTrials.gov registry record · Phase 2

Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma

A Phase 2 study of Carcinoma, Renal Cell, sponsored by Abbott.

Completed
Registry status
Phase 2
Development phase
103
Enrollment target
18
Study locations

NCT00073125 is a Phase 2 study of Carcinoma, Renal Cell that has completed, run by Abbott. The registered enrollment target is 103 participants, below the 280-participant average among 34 other Carcinoma, Renal Cell trials with a reported enrollment target (63% lower). The trial reports 18 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00073125, a Phase 2 study of Carcinoma, Renal Cell, has completed, sponsored by Abbott.

COMPLETED
Registry status
Phase 2
Development phase
103 participants
Enrollment target
18
Study locations

Study Summary

The primary objective of this study is to assess the safety and efficacy of ABT-510 in subjects with advanced renal cell carcinoma.

Conditions Studied

Carcinoma, Renal Cell

Interventions

  • DRUG ABT-510/Thrombospondin-1 mimetic

Study Locations (18)

Texas

  • US Oncology, P.A. - Dallas
  • Texas Cancer Center - Fort Worth
  • Texas Cancer Center - Fort Worth
  • MD Anderson Cancer Center - Houston
  • Baylor College of Medicine - Houston

Arizona

  • Virginia G. Piper Cancer Center - Scottsdale
  • Arizona Cancer Center - Tucson

California

  • UCLA School of Medicine - Los Angeles
  • Clinical Trials and Research Associates - Montebello

Florida

  • The Center for Hematology-Oncology - Boca Raton

Illinois

  • University of Chicago Medical Center - Chicago

Indiana

  • Central indiana Cancer Center - Indianapolis

Kansas

  • Kansas City Cancer Centers Southwest - Overland Park

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 103 participants
Start Date 2003-05
Phase Phase 2

Sponsor

Abbott

181 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00073125

The ClinicalTrials.gov registry entry for NCT00073125 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 280-participant average among 34 other Carcinoma, Renal Cell trials with a reported enrollment target (63% lower). The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Carcinoma, Renal Cell appearing as the primary indexed condition, and to 1 intervention - of which ABT-510/Thrombospondin-1 mimetic is the first listed.

NCT00073125 reports 18 study locations spanning 12 distinct geographic areas - top geographies include Texas, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT00073125 about?

NCT00073125 is a clinical study titled "Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma". The primary objective of this study is to assess the safety and efficacy of ABT-510 in subjects with advanced renal cell carcinoma.

What is the current status of trial NCT00073125?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 103 participants. The study started on 2003-05.

What conditions does trial NCT00073125 study?

This clinical trial studies the following conditions: Carcinoma, Renal Cell.

What interventions are being tested in trial NCT00073125?

The interventions under investigation include: ABT-510/Thrombospondin-1 mimetic (DRUG).

Who is sponsoring clinical trial NCT00073125?

This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00073125 being conducted?

This trial has 18 study locations across Arizona, California, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Carcinoma, Renal Cell

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Carcinoma, Renal Cell

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.